Screener
Jade Biosciences JBIO Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Jade Biosciences’s reported figures.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
FAQ
- What is Jade Biosciences's invested capital?
- Jade Biosciences (JBIO) reported invested capital of $242.19M in Q1 2026.
- How has Jade Biosciences's invested capital changed year-over-year?
- Jade Biosciences's invested capital increased by 290.1% year-over-year, from -$127.42M to $242.19M.
- What is the long-term trend for Jade Biosciences's invested capital?
- Over 4 years (2021 to 2025), Jade Biosciences's invested capital has grown at a 19.8% compound annual growth rate (CAGR), from $118.89M to $244.93M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Jade Biosciences's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude